| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of GCDH mRNA | affects expression | 21346803
|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of GCDH mRNA | affects expression | 21346803
|
| D000082 |
Acetaminophen |
Acetaminophen affects the expression of GCDH mRNA | affects expression | 17562736
|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of GCDH protein | affects expression | 20106945
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of GCDH mRNA | decreases expression | 20106945
|
| C006780 |
bisphenol A |
bisphenol A results in increased expression of GCDH mRNA | increases expression | 15223131
|
| D002995 |
Clofibric Acid |
Clofibric Acid affects the expression of GCDH mRNA | affects expression | 17602206
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of GCDH mRNA | decreases expression | 20106945
|
| C121718 |
dicyclanil |
dicyclanil results in increased expression of GCDH mRNA | increases expression | 15664270
|
| C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GCDH mRNA | affects binding|decreases expression|increases activity | 19710929
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GCDH mRNA | decreases expression | 18796159
|
| C066340 |
tolcapone |
tolcapone binds to GCDH protein | affects binding | 19783845
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.00 | 14514962 15322242 11752688 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.23 | 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.01 | 20127859 20464547 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.71 | 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
dicyclanil |
18.38 | 17162532 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
18.38 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
18.38 | 16835633 |
| MESH:D017109 |
Akathisia, Drug-Induced |
|
tolcapone |
6.47 | 11080934 |
| MESH:D000544 |
Alzheimer Disease |
|
tolcapone |
3.30 | 20150427 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
| MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.02 | 10982225 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.21 | 19183758 |
| MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.14 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.14 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
| MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.97 | 11985600 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.83 | 20146248 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.83 | 17123778 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.83 | 20435547 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
9.06 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
9.06 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
9.06 | 3084413 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
9.06 | 21507988 12619106 12907637 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
dicyclanil |
9.06 | 17162532 |
| MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.14 | 17123778 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.08 | 20419170 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 16120746 18670907 18850075 |
| MESH:D002386 |
Cataract |
|
Acetaminophen |
2.64 | 10977129 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.82 | 6135515 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.82 | 12371664 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.03 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.03 | 19176532 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 15340226 16354765 8697196 12621046 15668235 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 14669216 17141729 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.36 | 18551238 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.36 | 18551238 |
| MESH:D003866 |
Depressive Disorder |
|
tolcapone |
4.38 | 7768276 11224284 |
| MESH:D003865 |
Depressive Disorder, Major |
|
tolcapone |
5.00 | 10440460 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
12.35 | 18551238 21346803 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.35 | 18551238 21346803 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
12.35 | 19739265 19085960 11461765 15968718 16781746 16177239 14725611 11834606 19416960 12958197 12153990 17906064 19164858 18071297 19420014 10915739 16485898 11421492 17562736 16109766 12594235 12705907 11529661 11287661 14550746 17522070 11739529 16227642 12392966 16081117 16393943 10663392 14986274 12540782 2444490 11743745 18713872 19923254 19370779 10774834 15619225 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.35 | 20420201 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
tolcapone |
12.35 | 16604736 19783845 |
| MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.27 | 19426721 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
| MESH:D004409 |
Dyskinesia, Drug-Induced |
|
tolcapone |
5.57 | 11455177 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
6.90 | 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.90 | 12711302 11000095 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 15322242 18230668 16714409 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 10568697 9294722 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.03 | 16530937 |
| MESH:D054908 |
Extensively Drug-Resistant Tuberculosis |
|
tolcapone |
6.12 | 19578428 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.93 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.93 | 19236843 20131406 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.95 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.95 | 20067830 |
| MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.85 | 16983495 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.37 | 8708960 |
| MESH:C536833 |
Glutaric aciduria 1 |
marker/mechanism |
|
| |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.63 | 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.63 | 11294989 10048152 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.60 | 20558911 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.58 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.73 | 16221962 19176532 18467677 19772884 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.73 | 15340226 12621046 16120746 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 8697196 16354765 15340226 18606429 16959395 |
| MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.79 | 16870215 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.29 | 20558911 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.07 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.07 | 18670907 18850075 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.91 | 12200463 12878042 |
| MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.55 | 16393666 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.55 | 16306350 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.62 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.99 | 12587719 15629191 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.99 | 18776723 8314463 10903974 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
12.91 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.91 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.91 | 12371664 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.16 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.16 | 12878042 |
| MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.65 | 19784758 16611625 19460945 12587719 19014921 16610002 11587558 12969438 |
| MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.34 | 17185352 16871587 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
22.53 | 7678174 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
22.53 | 2125692 18177683 9163691 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
22.53 | 21137059 20195826 |
| MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
22.53 | 17602206 |
| MESH:D008113 |
Liver Neoplasms |
|
dicyclanil |
22.53 | 20118626 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
22.53 | 20007298 16377806 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
22.53 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.19 | 2876784 2876786 6135515 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
10.19 | 8603461 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.19 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.42 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.42 | 18816296 6695378 20464547 17053015 18569708 20869020 20064080 20135361 18520028 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.42 | 19555203 11884234 |
| MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.71 | 19513568 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.96 | 16801185 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.27 | 16381670 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.18 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.03 | 16411023 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.87 | 18551238 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.87 | 7678174 18551238 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.99 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.99 | 17405874 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.62 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.38 | 18481113 19348381 |
| MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
10.01 | 11399458 16427766 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.01 | 14600291 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.96 | 18514411 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.23 | 12819281 16049721 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.23 | 16049721 |
| MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.14 | 11985600 |
| MESH:D010146 |
Pain |
|
Acetaminophen |
2.48 | 16870215 |
| MESH:D010300 |
Parkinson Disease |
|
tolcapone |
3.63 | 11432539 8635184 20334432 9708959 7566641 16758261 19578428 9591521 11793426 9305320 10651109 1977408 18328768 20216409 9754991 11586115 8739811 17089403 19783845 11746615 9333106 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.32 | 12371664 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
10.03 | 10548101 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.03 | 11118676 11399792 11896295 11222880 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.32 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.20 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.20 | 16740699 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.26 | 16882103 |
| MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.94 | 10548101 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.11 | 18551238 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.11 | 18551238 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.63 | 19755658 10029692 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.63 | 16192470 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
| MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.14 | 16045194 16684133 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
| MESH:D018088 |
Tuberculosis, Multidrug-Resistant |
|
tolcapone |
6.12 | 19578428 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.50 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.50 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.50 | 17053015 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.51 | 10091137 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.51 | 10091137 |
| MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.09 | 10982225 |
| MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.18 | 14652134 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.16 | 1336536 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
| MESH:D014820 |
Vitiligo |
|
tolcapone |
5.32 | 10573327 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.62 | 17120751 |